Atara Biotherapeutics (ATRA) Q3 2026 Earnings Report
CH:ATRA Q3 2026 EPS Results
- Actual EPS
- ―
- Consensus EPS
- -CHF 0.11
- Beat/Miss
- ―
- One Year Ago EPS
- -CHF 0.26
CH:ATRA Q3 2026 Revenue Results
- Actual Revenue
- ―
- Expected Revenue
- CHF 659.84K
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 10/29/2026
- Time
- TBA
- Conference Call
- Thursday, October 29, 2026
CH:ATRA Upcoming Earnings
Atara Biotherapeutics's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:ATRA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | ―- | -0.21 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | -0.11- | -0.26 | ― | |
| Aug 12, 2026 | 2026 (Q2) | -0.26-0.26 | 0.16 | -268.42% (-0.42) | |
| May 12, 2026 | 2026 (Q1) | -0.27-0.24 | 2.89 | -108.29% (-3.13) | |
| Mar 16, 2026 | 2025 (Q4) | -0.15-0.21 | -0.98 | 78.99% (+0.78) | |
| Nov 29, 2025 | 2025 (Q3) | -0.55-0.26 | -2.42 | 89.08% (+2.15) | |
| Aug 11, 2025 | 2025 (Q2) | -0.050.16 | -2.56 | 106.13% (+2.71) | |
| May 15, 2025 | 2025 (Q1) | -1.632.89 | -4.74 | 160.87% (+7.63) | |
| Mar 07, 2025 | 2024 (Q4) | -2.36-0.98 | -11.55 | 91.50% (+10.57) | |
| Nov 12, 2024 | 2024 (Q3) | -1.56-2.42 | -13.61 | 82.24% (+11.19) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
